Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001178913-25-002313
Filing Date
2025-07-07
Accepted
2025-07-07 09:29:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA 14A zk2533414.htm DEFA14A 27596
2 image0.jpg GRAPHIC 385923
  Complete submission text file 0001178913-25-002313.txt   560254
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-42253 | Film No.: 251107151
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)